Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Others
    (2)
Filter
Search Result
Results for "

ly-354740

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
Eglumetad monohydrate
LY-354740, LY354740, LY 354740, Eglumetad, Eglumegad
T202275209216-09-1
Eglumetad (also known as LY354740) is an investigational compound developed by Eli Lilly and Company, currently under research for the treatment of anxiety disorders and substance addiction. This compound originates from glutamate, demonstrating a novel mechanism of action.
  • Inquiry Price
Size
QTY
Eglumegad
Eglumetad,LY354740
T15817176199-48-7
Eglumegad is a highly effective and selective agonist of group II (mGlu2/3) receptor (IC50s: 5 and 24 nM on transfected human mGlu2 and mGlu3 receptors, respectively).
    7-10 days
    Inquiry
    Eglumegad hydrochloride
    LY354740 hydrochloride, Eglumetad hydrochloride
    T78094
    Eglumegad (LY354740) hydrochloride is a potent, selective agonist for group II (mGlu2 3) receptors, showing IC50 values of 5 nM for mGlu2 and 24 nM for mGlu3 receptors in transfected human cells. This compound provides neuroprotection against NMDA-induced toxicity and exhibits anxiolytic- and antipsychotic-like properties [1].
      Inquiry